Macromastia Clinical Trial
Official title:
A Prospective, Randomized, Controlled Study to Evaluate Cutaneous Scar Quality Following Bilateral Breast Reduction With the PEAK PlasmaBlade 4.0
The objective of this clinical study is to evaluate scar quality following incision with the PEAK PlasmaBlade 4.0 using the Patient and Observer Scar Assessment Scale (POSAS), and to compare these results to equivalently-aged scars formed following incision with a standard scalpel.
Subjects attended one of two evaluation dates scheduled on January 21, 2011 and February 23, 2011. During this visit, subjects gave informed consent and were instructed on evaluating their breast reduction scars using the Patient Scar Assessment Scale. Following subjects' self-evaluation, each subject was evaluated by three evaluators using the Observer Scar Assessment Scale. ;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05288530 -
Satisfaction, Pain and Function Outcomes of Breast Reduction Patients
|
||
| Completed |
NCT00986453 -
PEAK PlasmaBlade 4.0 in Bilateral Breast Reduction
|
N/A | |
| Completed |
NCT02769559 -
Reduction Mammaplasty and Improved Quality of Life
|
N/A | |
| Terminated |
NCT02016677 -
An Observational Study Exploring the Esthetic Outcomes of Breast Reduction Surgery and /or Mastopexy
|
N/A | |
| Completed |
NCT00558246 -
Study of Prineo (Dermabond Protape) Versus Sutures in Breast Procedures
|
Phase 4 | |
| Recruiting |
NCT05898087 -
Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
|
Phase 4 |